Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hannah Daniel

Reporter

Hannah joined Medtech Insight from HBW Insight in August 2022 and reports on cybersecurity, patent law and other facets of medical device regulation. Hannah is passionate about the intersection of science and communication and holds a bachelor’s degree in biology from Carnegie Mellon University.

Latest From Hannah Daniel

MDR Changes Aren’t A ‘Catalyst’ For Medtech Investments In Ireland

IDA Ireland’s Rachel Shelly tells Medtech Insight about what is (and isn’t) driving investment in medtech. 

Digital Health Regulation

News We’re Watching: Biden Moves To Strengthen Supply Chain; More Medtech-Related Prosecutions; $5.5M Sepsis Grant For Siemens

This week, the Biden administration announced a new council on supply chain resilience that includes health care goals; an apparent enforcement surge against device fraud continued; Siemens won a $5.5m grant to develop a better sepsis test; and the FDA proposed new classifications for wound care products.

Policy Regulation

Medtech Advocate Announces Retirement From House Of Representatives

Medical device advocate Anna Eshoo has announced that she plans to retire from Congress after three decades.

Politics Policy

Report: HDO Mutual Aid Can Provide Legacy Device Security

A report from MITRE recommends mutual aid partnerships between large and small HDOs to secure legacy medical devices.

Cybersecurity Regulation

Policy Misalignment Is Harming AI Development, Experts Say

Experts lamented the lack of consensus standards for AI medical devices, which they said could pose harm to innovators.

Artificial Intelligence Policy

‘We Need To Be Transparent About Our Failures,’ Experts Say About AI Development

 Stakeholders discussed the need for transparency and explainability of AI models at the AI Summit in Cincinnati. 

Artificial Intelligence Regulation
See All
UsernamePublicRestriction

Register